Karolinska Development's Annual Report 2010 published

Karolinska Development's Annual Report 2010 published

ID: 53622

(Thomson Reuters ONE) -


STOCKHOLM - April 15, 2011. Karolinska Development's Annual Report 2010 is now
published and available on the company's website: www.karolinskadevelopment.com.

For further information, please contact:

Torbjörn Bjerke, President and CEO
Phone: +46 72 744 41 23, e-mail: torbjorn.bjerke(at)karolinskadevelopment.com

Gunnar Casserstedt, CFO
Phone: +46 73 068 37 00, e-mail: gunnar.casserstedt(at)karolinskadevelopment.com

Benjamin Nordin, IR Director
Phone: +46 73 093 60 80, e-mail: benjamin.nordin(at)karolinskadevelopment.com




TO THE EDITORS

About Karolinska Development
Karolinska Development aims to create value for investors, patients, and
researchers by developing innovations from world class research into products
that can be sold or out-licensed with high returns. The business model is to:
SELECT the most commercially attractive medical innovations; DEVELOP these to
the stage where the greatest return on investment can be achieved; and
COMMERCIALIZE the innovations through the sale of companies or out licensing of
products. This will result in upfront payments, milestone payments and
royalties.

An exclusive deal flow agreement with Karolinska Institutet Innovations AB,
along with other cooperation agreements with leading Nordic universities,
delivers a continuous flow of innovations.

Karolinska Development's flexible exit strategy enables projects to be exited at
whichever stage of development offers the greatest return on investment, usually
after Phase II clinical trials have indicated the desired pharmaceutical effect
on patients - this being an important value enhancing step.

Today, the portfolio consists of over 40 projects at various stages, from
concept development to Phase II clinical trials, twelve projects are in clinical
trials with six in Phase II. The portfolio is particularly strong in the areas




of cancer, dermatology, inflammation, cardiovascular disease, women's health and
diseases that affect the central nervous system. www.karolinskadevelopment.com







This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Karolinska Development AB (publ) via Thomson Reuters ONE

[HUG#1506998]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Index Levels and Weightings IMSK- 1Q result 2011
Bereitgestellt von Benutzer: hugin
Datum: 15.04.2011 - 17:26 Uhr
Sprache: Deutsch
News-ID 53622
Anzahl Zeichen: 2851

contact information:
Town:

Solna



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 171 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Karolinska Development's Annual Report 2010 published"
steht unter der journalistisch-redaktionellen Verantwortung von

Karolinska Development AB (publ) (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Karolinska Development AB (publ)



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z